☰

Madhu Sanga, Ph.D. - Publications

Affiliations: 
2004 West Virginia University, Morgantown, WV, United States 
Area:
Pharmacy, Toxicology, Pharmacology
Tree Info Similar researchers PubMed Report error

2 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Sanga M, James J, Marini J, Gammon G, Hale C, Li J. An Open-Label, Single-Dose, Phase I Study of the Absorption, Metabolism, and Excretion of Quizartinib, a Highly Selective and Potent FLT3 Tyrosine Kinase Inhibitor, in Healthy Male Subjects, for the Treatment of Acute Myeloid Leukemia. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 1-43. PMID 27460866 DOI: 10.1080/00498254.2016.1217100  0.346
2012 Li J, Bresnahan G, Gammon G, Sanga M, Hale C, Hashimoto T, Gill S, James J. Absorption, Metabolism, and Excretion of Quizartinib (AC220), a FLT3 Tyrosine Kinase Inhibitor for Treatment of Acute Myeloid Leukemia, in Healthy Male Volunteers Blood. 120: 4327-4327. DOI: 10.1182/Blood.V120.21.4327.4327  0.313
Show low-probability matches.